Effects of Performing Arts on Attention-deficit/Hyperactivity Disorder (ADHD)
NCT07318935, Not applicable, Completed, Virginia Polytechnic Institute and State University
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Effects of Performing Arts on Attention-deficit/Hyperactivity Disorder (ADHD) | ClinicalTrials.gov |
| NCT number | NCT07318935 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 69 participants, actual | ClinicalTrials.gov |
| Lead sponsor | Virginia Polytechnic Institute and State University | ClinicalTrials.gov |
| Conditions | ADHD | ClinicalTrials.gov |
| Interventions | Dance Exergaming, Stationary Cycling, Music Listening | ClinicalTrials.gov |
| First posted | 2026-01-06 | ClinicalTrials.gov |
| Last updated | 2026-01-06 | ClinicalTrials.gov |
Registered outcomes 21
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | ADHD Symptom Severity | Within 1 week prior to and after invention | Total score (0 to 72) on the Adult ADHD Self-Report Scale (ASRS) - v 1.1; higher scores indicate greater symptom severity | ClinicalTrials.gov |
| Secondary | Depression level | Within 1 week prior to and after invention | Total score (0 to 63) on the Beck Depression Inventory II (BDI-II); higher scores indicate greater symptom severity | ClinicalTrials.gov |
| Secondary | Anxiety level | Within 1 week prior to and after invention | Total score (0-63) on the Beck Anxiety Inventory (BAI); higher scores indicate greater symptom severity | ClinicalTrials.gov |
| Secondary | Attention | Within 1 week prior to and after invention | Response time (ms) on the Stroop Color-Word Task for congruent and incongruent trials; lower values indicate faster/better response times | ClinicalTrials.gov |
| Secondary | Inhibition | Within 1 week prior to and after invention | Response time (ms) on the Go-/No-Go Task; lower values indicate faster/better response times | ClinicalTrials.gov |
| Secondary | Inhibition | Within 1 week prior to and after intervention | Percentage correct (%) on the Go-/No-Go Task; higher scores indicate better performance | ClinicalTrials.gov |
| Secondary | Cognitive Flexibility | Within 1 week prior to and after invention | Percentage correct (%) on Wisconsin Card Sorting Task; higher scores indicate better performance | ClinicalTrials.gov |
| Secondary | Cognitive flexibility | Within 1 week prior to and after intervention | Ability to learn task rules on Wisconsin Card Sorting Task (number or errors each time a new rule is introduced); positive score indicates improved performance whereas negative score indicates deteriorating performance | ClinicalTrials.gov |
| Secondary | Working Memory | Within 1 week prior to and after invention | Forward and backward recall (number of items recalled) on the Visual Digit Span Task; higher scores indicate better performance | ClinicalTrials.gov |
| Secondary | Balance | Within 1 week prior to and after invention | Force plate assessment in shoulder width and tandem stance measured via center of pressure (root mean square distance from the mean); higher values indicate lower stability | ClinicalTrials.gov |
| Secondary | Balance | Within 1 week prior to and after intervention | Force plate assessment in shoulder width and tandem stance measured via center of pressure (average velocity of the center of pressure); higher values indicate lower stability | ClinicalTrials.gov |
| Secondary | Neural state during rest | Within 1 week prior to and after invention | Power (log-transformed power in microvolts squared) in theta (4-8 hz), alpha (8-12 hz), beta (12-30 hz), and gamma (30-55 hz) frequency bands during a 5-minute resting baseline brain state; higher values indicate greater power | ClinicalTrials.gov |
| Secondary | Neural state during cognitive tasks | Within 1 week prior to and after intervention | Power (log-transformed power in microvolts squared) in theta (4-8 hz), alpha (8-12 hz), beta (12-30 hz), and gamma (30-55 hz) conducted during cognitive task assessment | ClinicalTrials.gov |
| Secondary | Neural state during cognitive tasks | Within 1 week prior to and after intervention | Amplitude of event-related potentials during cognitive tasks; higher value indicates a greater neural response to the task-stimulus - interpretation is component-specific | ClinicalTrials.gov |
| Secondary | Neural state during cognitive tasks | Within 1 week prior to and after intervention | Latency of event-related potentials during cognitive tasks; lower value indicates a faster neural response to the task-stimulus - interpretation is component-specific | ClinicalTrials.gov |
| Other | Sex | Within 1 week prior to intervention | Sex at birth including female or male | ClinicalTrials.gov |
| Other | Age | Within 1 week prior to intervention | Age, ranging from 18 to 24 | ClinicalTrials.gov |
| Other | Race | Within 1 week prior to intervention | Race including American Indian/Alaska Native, Asian, Black or African American, Native Hawaiian or Other Pacific Islander, White, or more than one race/other | ClinicalTrials.gov |
| Other | Ethnicity | Within 1 week prior to intervention | Ethnicity including Hispanic/Latino or not Hispanic/Latino | ClinicalTrials.gov |
| Other | Education level | Within 1 week prior to intervention | Education level including finished high school or GED, some college, bachelor's degree, or advanced degree | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 3
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Card Sorting Test (Berg) | Secondary outcome | ConductCognition |
| Digit Span Test | Secondary outcome | ConductCognition |
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)